Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Nasopharyngeal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01797900
What this trial is testing

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Who this might be right for
Nasopharyngeal Neoplasms
Chinese Academy of Medical Sciences 130
Large-scale testing (Phase 3)Active Not RecruitingNCT01706939
What this trial is testing

The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

Who this might be right for
Squamous Cell Carcinomas
Icahn School of Medicine at Mount Sinai 23
Early research (Phase 1)Study completedNCT00049283
What this trial is testing

Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the Larynx+24 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT01313390
What this trial is testing

Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University College, London 4
Testing effectiveness (Phase 2)Study completedNCT00720304
What this trial is testing

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 43
Not applicableStudy completedNCT00388024
What this trial is testing

PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck Cancer
Wake Forest University Health Sciences 19
Large-scale testing (Phase 3)UnknownNCT03015727
What this trial is testing

Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 440
Large-scale testing (Phase 3)Study completedNCT00778908
What this trial is testing

Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Guangxi Medical University 120
Large-scale testing (Phase 3)Looking for participantsNCT05062005
What this trial is testing

ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 447
Large-scale testing (Phase 3)Not Yet RecruitingNCT06561763
What this trial is testing

TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
High Risk Locally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University 416
Large-scale testing (Phase 3)Looking for participantsNCT06026878
What this trial is testing

GNT Induction Treatment in Locally Advanced NPC

Who this might be right for
Nasopharyngeal Carcinoma
Air Force Military Medical University, China 228
Large-scale testing (Phase 3)UnknownNCT03656965
What this trial is testing

EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug

Who this might be right for
Drug Use for Unapproved Schedule
Kuwait Cancer Control Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT06811844
What this trial is testing

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

Who this might be right for
Nasopharyngeal NeoplasmsPD-1 InhibitorInduction Therapy+2 more
The First Affiliated Hospital of Xiamen University 208
Testing effectiveness (Phase 2)Study completedNCT04508816
What this trial is testing

Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 45
Testing effectiveness (Phase 2)Looking for participantsNCT06055816
What this trial is testing

Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT07332247
What this trial is testing

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC

Who this might be right for
Nasopharangeal CancerRecurrent Nasopharynx Carcinoma
Sun Yat-sen University 94
Testing effectiveness (Phase 2)UnknownNCT04447326
What this trial is testing

Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University 106
Not applicableUnknownNCT03657017
What this trial is testing

PET/MR in Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaPET/MR
Zhejiang Cancer Hospital 150
Not applicableNot Yet RecruitingNCT07399158
What this trial is testing

CROSSROAD: Treatment Regimen Switch - Re-induction Chemotherapy vs. Direct Radiotherapy in LANPC With Inadequate Response to Induction Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 223
Testing effectiveness (Phase 2)Looking for participantsNCT05397769
What this trial is testing

Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.

Who this might be right for
Locally Advanced Nasopharyngeal CarcinomaEnvafolimabInduction Chemotherapy+1 more
Sun Yat-sen University 36
Next Page